An observational study in Oligohydramnios, Delivered, sponsored by Zagazig University. Completed at 1 site in Saudi Arabia. Open to female participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-09-30.
Sponsored by Zagazig University · Observational
Oligohydramnios happens in 1-5% of term pregnancies. The clinical significance of isolated oligohydramnios been a matter of debate. We aimed in this study to investigate the impact of isolated oligohydramnios on the mode of delivery and risk of adverse perinatal outcome.
Retrospective study conducted in Armed Forces Hospitals of Southern Region, comparing cases with oligohydramnios (amniotic fluid level index \<5) to normal amniotic fluid cases (amniotic fluid level index ≥ 8). Primary outcomes are the mode of delivery and adverse perinatal outcomes (including mortality, NICU admission, low Apgar score and sepsis)
25 studies on the registry are indexed under Oligohydramnios; 5 are open to participants now.
Browse Oligohydramnios studies →Zagazig University is the lead sponsor of 459 studies on the registry; 77 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Pregnant women between 32 and 41 weeks with otherwise normal pregnancy. Isolated oligohydramnios group are diagnosed with amniotic fluid index less than 5.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Cases with oligohydramnios (amniotic fluid index less than 5) without an overt underlying reason in the third trimester
Behavioral: observation of delivery and neonatal outcomes
Normal pregnancy cases with normal amniotic fluid index
Behavioral: observation of delivery and neonatal outcomes
MONITORING THE DELIVERY MODE EITHER CESAREAN OR VAGINAL, BESIDE THE NEONATAL OUTCOME AND MORBIDITIES IN BOTH GROUPS
Delivery mode
Either vaginal delivery or cesarean section
Time frame: through study completion, an average of 1 year
Composite neonatal outcomes
Risk of low Apgar score, transient tachypnea of newborn, ICU admission, etc
Time frame: through study completion, an average of 1 year
Induction of labor rate
Comparing incidence of labor induction between both groups and between gestational age groups
Time frame: through study completion, an average of 1 year
Plan to share: Undecided
This study is completed, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.